# PROTEOGENIX INC: Form D filings

PROTEOGENIX INC, a biotechnology company in Costa Mesa, CA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on April 14, 2010, reports $4 million sold of a $4.4 million offering to 5 investors.

Find out what PROTEOGENIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PROTEOGENIX%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PROTEOGENIX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fproteogenix-inc-1179366)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PROTEOGENIX%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PROTEOGENIX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fproteogenix-inc-1179366)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3545 HOWARD WAY, Costa Mesa, CA, 92626
- Phone: (714) 445-0100
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2007
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1179366

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 14, 2010 | New notice | $4,400,000 | $4,000,000 | $400,000 | 5 | Apr 5, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1179366/000117936610000001/0001179366-10-000001-index.htm) |
| Aug 13, 2009 | New notice | $4,002,500 | $4,002,500 | $0 | 5 | Aug 12, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1179366/000117936609000004/0001179366-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Donald Mooney | Executive Officer, Director |  |
| Mike E. Allen | Executive Officer |  |
| Steven G. Burrill | Director |  |
| Michael G. Gravett | Executive Officer |  |
| Richard G. Creager | Director |  |
| Srinivasa Nagalla | Director |  |
| Fred G. Cohen | Director |  |
| Thomas E. Grove | Executive Officer |  |
| David G. Levison | Director |  |
| Vijay G. Lathi | Director |  |
| Durlin E. Hickok | Executive Officer |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of Apr 12, 2010](https://specstream.ai/data/form-d/week/2010-04-12) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PROTEOGENIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).